Cibus, Inc. quarterly report, Q1 FY2020

Business context and reporting period

Filing identity mismatch: The supplied filing is Calyxt, Inc. (Nasdaq: CLXT), not Cibus, Inc. It covers the quarter ended March 31, 2020, and was filed May 6, 2020.

Calyxt is an agricultural technology company commercializing high-oleic soybean oil and meal, while developing a broader crop pipeline. It reported 18 projects at the Discovery stage or later. Cellectis owned 68.8% of Calyxt at quarter-end.

Financial performance and liquidity

• Revenue rose $2.220 million year over year as commercial product sales grew. Soybean meal represented 87% of Q1 2020 revenue. Most oil revenue came from one customer, with remaining orders expected to be fulfilled over the following six months.
• Cost of goods sold was $3.884 million and included a $1.1 million inventory net realizable value adjustment. The company attributed negative gross margin to costs at this early stage of commercialization.
• Cash, cash equivalents, short-term investments and restricted cash totaled $47.438 million at March 31, 2020, versus $85.732 million a year earlier. The balance included $38.620 million of short-term investments, reflecting a shift from cash into securities as well as operating cash use.
• Total liabilities were $23.885 million, including $18.555 million of financing lease obligations ($18.194 million non-current and $0.361 million current). Current liabilities were $5.550 million.
• Investing cash outflow of $38.759 million was principally the purchase of short-term investments. Financing cash outflow was $0.045 million.

Material changes versus the prior comparable period

• Revenue increased sharply from a small comparison base following the launch of high-oleic soybean oil and meal in 2019, but the gross margin moved from positive to negative.
• Net loss widened by $3.688 million. The company cited weaker gross margin, higher personnel and professional-service costs, and a $0.570 million year-over-year reduction in net interest income.
• R&D expense rose 25.6% to $2.787 million; selling and supply-chain expense rose 74.8% to $1.580 million; and G&A expense rose 13.4% to $4.720 million. Management fees fell to $0.062 million from $0.361 million after the company internalized services previously provided by Cellectis.
• Operating cash use increased $3.140 million year over year. The company reported an accumulated deficit of $133.120 million.

Outlook, risks and unusual items

• COVID-19: Calyxt reported lower vegetable-oil demand and pricing pressure beginning late in Q1, and anticipated depressed demand and prices into the second half of 2020 or longer. It also cited potential weaker meal demand connected to disruptions in protein processing.
• The company canceled crushes scheduled for late May, June and July, accelerated purchases of remaining 2019 grain, began reviewing operating expenses, and postponed non-essential capital spending. Management expected lower monthly cash use from April and projected runway into late 2021, subject to assumptions and uncertain conditions.
• On April 19, 2020, Calyxt received a $1.5175 million Paycheck Protection Program loan at 1% interest, potentially forgivable if specified conditions are met. This was a subsequent event, not cash received by quarter-end.
• Management said Q1 R&D and seed distribution had not experienced material delays and supply-chain disruption had not yet materially affected operations, but warned that further closures or transportation and processing interruptions could do so.
• Other risks include early-stage commercialization and continued operating losses, customer concentration in oil sales, reliance on third-party growers and processors, commodity-price exposure, and the possibility that future financing may be difficult or costly. The company had $9.2 million of grain and seed purchase commitments tied to 2020 production, subject to stated cancellation conditions.
• The filing’s non-GAAP gross-margin presentation is internally inconsistent: the narrative describes adjusted gross margin as negative $1.2 million, while the extracted reconciliation table shows positive $1.174 million, despite listing a negative 49% margin. The adjusted gross-margin dollar value is therefore unclear from the filing text provided.
• No material pending legal proceeding was reported. Management stated disclosure controls were effective as of March 31, 2020.

Most important facts for investors to verify

1. Confirm the issuer: this is a Calyxt, Inc. 10-Q, not a Cibus, Inc. filing.
2. Check the original filing’s non-GAAP reconciliation for the adjusted gross-margin sign and amount.
3. Assess whether management’s projected cash runway into late 2021 remains supportable given operating cash use, COVID-related demand and pricing pressures, and planned expense reductions.
4. Track the concentrated oil customer’s remaining orders, subsequent sales, product pricing, and the timing of any recovery in oil and meal demand.
5. Verify the PPP loan’s forgiveness status and any remaining repayment obligations.